In hepatocellular carcinoma (HCC), SPP1-positive macrophages and CAFs participate in the formation of the ECM, promoting the formation of TIB (Tumor immune barrier) structures, and preventing CD8+ T cells from infiltrating into TIB-coated tumors (74). This evidence concerns the gene CD8A and hepatocellular carcinoma.